DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

7.08 0.30 (4.42%)

REAL-TIME: Last trade at

Extended Hours: $7.08 $0.00 (-0.01%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

PGNX $7.08 4.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.80
Previous Close $6.78
Daily Range $6.64 - $7.14
52-Week Range $3.10 - $7.45
Market Cap $492.5M
P/E Ratio 61.64
Dividend (Yield) $0.00 (0.0%)
Volume 1,492,822
Average Daily Volume 1,076,204
Current FY EPS -$0.05

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ...

Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker Q3 2014 Results - Earnings Call Transcript

Morning Market Movers

Looking For My Next Triple In Biotech

Phase 2 Data for Progenics' 1404 Imaging Agent Presented at EANM Congress

Progenics Gets $40M Milestone on FDA Approval of Relistor - Analyst Blog

See More PGNX News...

PGNX's Top Competitors

PGNX $7.08 (4.42%)
Current stock: PGNX
AMGN $162.24 (-1.18%)
Current stock: AMGN
GILD $101.11 (0.51%)
Current stock: GILD
BIIB $305.40 (-0.44%)
Current stock: BIIB